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Drug stock-outs: Inept supply-chain 
management and corruption
The National Health 
Department is urgently 
trying to source and install 
a countrywide computer 
software system that will 
link healthcare facilities with drug depots 
and suppliers in order to relieve ongoing 
essential drugs stock-outs which threaten 
the lives of thousands of patients. The issue 
has become a national crisis, affecting 
districts in 8 of the 9 provinces. 
Contributing factors include a shortage 
of pharmacists, protracted labour disputes, 
dismal management, corruption, and woeful 
communication between suppliers, depots 
and facilities. Reports from HIV clinicians 
and fieldworkers, plus a collective probe by 
4 influential NGOs, reveal that only adept 
clinical management of patients is preventing 
the emergence of widespread drug resistance 
and a rise in morbidity and mortality. 
According to the NGO report – compiled 
by the Rural Health Advocacy Project, 
Médecins Sans Frontières, the Treatment 
Action Campaign and +Section 27 – one of 
the worst examples is the Mthatha depot. In 
November last year the depot was described 
as ‘anarchic and beyond redemption’ by the 
then Eastern Cape Health Superintendent 
General, Dr Siva Pillay. This January, 24% 
of drug-prescribed patients were turned 
away from the 300 facilities the depot serves 
across 17 districts of the sprawling Oliver 
Tambo region, while 53% of the clinics 
and hospitals it serves suffered antiretroviral 
(ARV) or tuberculosis (TB) drug stock-outs, 
including shortages of the new fixed-dose 
combination (FDC) ARVs. These stock-outs 
lasted on average 45 days at a time and 
remained ‘almost as common and severe as 
they were 5 months ago’, according to the 
report.
Former health chief: 
‘Shut it down, bring in 
the army’
An estimated 100 000 patients depend on the 
Mthatha depot for their ARV drug supplies 
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– giving some idea of the potential impact of 
similar dysfunctional facilities nationwide. 
The report found that the Eastern Cape 
Health Department’s suspension of 29 depot 
staff late last year, without a plan to provide 
services in their absence, contributed 
significantly to the crisis. At the time of 
writing, the depot still had no full-time 
manager and was operating with half its 
usual number of staff. 
There were other reasons for the 
province’s stock-out crisis. Between May and 
November 2011, 19 tons of medicines stored 
at the Mthatha and Port Elizabeth depots, 
plus the province’s 92 healthcare facilities, 
were destroyed after being ‘tampered with’ 
or because they had passed their expiration 
dates. Earlier in 2011, 16 tons of medicines 
and surgical products were destroyed in 
a fire allegedly set at the Mthatha depot 
after Pillay ordered a sudden audit of the 
facility. In a ‘sting’ operation by the Hawks 
police unit, 3 health department pharmacy 
assistants and a municipal official were later 
arrested and a municipal vehicle impounded, 
in connection with the ‘theft-for-sale’ of an 
estimated R220 000-worth of medications 
from this and a nearby depot. According 
to documents in Izindaba’s possession, the 
Mthatha depot issues a monthly average of 
R24 million worth of stock; however, from 
mid-September to December last year, it 
issued just R4 million worth. 
In a November 2012 report Pillay 
described the depot as ‘unmanageable 
and unnecessary’ because it was ‘rife with 
corruption, widespread theft and labour 
problems’. He proposed bringing in the army 
to stem ongoing losses, which he estimated 
at R250 million a year, replacing the removed 
staff with temporary staff (to catch up on 
the month-long backlog), and then shutting 
the depot down entirely, moving operations 
to Port Elizabeth. In the long term, he 
proposed implementing, as a pilot project, 
the national health department’s intended 
strategy of getting suppliers to deliver 
directly to healthcare facilities. His proposals 
were vetoed by his political superiors.
Not just HIV and 
TB meds
The NGO probe found that, nationally, 
mismanagement exacerbated a chronic cycle 
of over-ordering by health facilities as the 
result of poor stock-keeping. In many cases, 
orders are radically out of step with actual 
need. The ‘vicious cycle’ is amplified by 
national drug shortages, leading to rationing 
of supplies to depots, which then adjust 
orders from facilities downwards.
The probe also found that it’s not only 
HIV and TB drugs running out across most 
provinces, but also a ‘wide range’ of essential 
medicines. Both large and small facilities 
are affected, with the latter particularly 
vulnerable as they are at the end of the 
supply-chain management line, and suffer 
from mistakes accumulated along the way. 
Lamivudine and tenofovir were the ARVs 
most frequently out-of-stock nationwide. 
The frequency of individual stock-out 
reports, combined with the assessment of 
those on the ground, suggest that Gauteng is 
also particularly badly affected, with patients 
reporting province-wide shortages of 
lamivudine and, to a lesser extent, tenofovir. 
Reports reaching the NGOs and other civil 
society organisations suggest that this is ‘the 
tip of the iceberg,’ because many stock-outs 
and their impact have gone unreported. In 
Ekurhuleni, at least 8 clinics were affected 
by lamivudine and tenofovir stock-outs. 
KwaZulu-Natal’s Eshowe Hospital reported 
low supplies of tenofovir and ‘indications of 
stock mismanagement’ from the hospital to 
its surrounding clinics, which also reported 
FDC shortages and stock-outs of paediatric 
ARV dosages. In Limpopo, Messina Hospital 
ran short of tenofovir, lamivudine was out 
of stock at the province’s main depot and 
stavudine was in short supply at several 
health facilities. The only province to escape 
mention in the damning report was the 
Western Cape.
Confronted with drug shortage claims from 
HIV clinicians in Gauteng, and elsewhere, 
Dr Yogan Pillay, National Deputy Director 
General for HIV/AIDS, TB, Maternal, Child 
and Women’s Health, accused facilities of 
‘hoarding’ drugs. However, he admitted that 
his department does not know individual 
facilities’ stock levels. ‘Where there are facility 
stock-outs we look at who else has supplies. 
Often the depot has to look for stocks. From 
a national perspective we know exactly what’s 
short, but we have no way of knowing what’s 
happening at facilities. We also get figures 
from suppliers. Depot supplies we have a fix 
on, but facilities – zero,’ he admitted. He said 
the department is trying to install a system 
that will link facilities’ computer software 
with that of depots and suppliers to enable 
better management. 
He rebuffed claims by Professor Francois 
Venter, the deputy executive director of 
the University of the Witwatersrand (Wits) 
Reproductive Health and HIV Research 
Institute and former head of the South African 
Eastern Cape Health MEC Sicelo Gqobana surveys R220 000 worth of medicines stolen from the 
Mthatha depot in May 2011. The red municipal van was used to transport the drugs.
Dr Yogan Pillay, National Deputy Director 
General for HIV/AIDS, TB, Maternal, Child and 
Women’s Health. Picture: Chris Bateman
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HIV Clinician’s Society, that drug stock-outs 
were responsible for a near-riot late last year 
among patients at the Wits Esselen Street 
Clinic in Hillbrow, which is mainly attended 
by sexworkers. Yogan Pillay said, ‘[The clinic’s] 
problem is they don’t know how much to 
order on a month to month basis – and their 
clients come from all over the place.’ 
Venter scoffed at this, saying ‘We know 
exactly what to order.’ He pointed out that 
the problem extends to the province and 
entire country.
Accountability like 
‘chasing ghosts’
Added Venter, ‘The reasons are probably 
quite complex, but it all comes down to 
management of the supply chain. It’s 
frustrating that you never know who to blame 
or hold accountable. Patients suffer. I must 
admit I have yet to see ARV resistance or 
patients dying because of a lack of drugs – it 
may be hidden and they’re dying at home – 
but it’s only a matter of time before it happens.’ 
He cited one case in which a clinic 
manager had 2 000 patients on treatment , 
while the depot reported enough drugs for 
only 1 000. Meanwhile another clinic got 
supplies for 3 000 patients – when they had 
only ordered for 1 000. ‘You get the strangest 
reports, and it’s not just ARV’s. We’ve run 
out of meningitis drugs, antibiotics. OK, last 
year one drug company fell over and couldn’t 
do the volumes, but in most cases the drugs 
just don’t get from the depot to the patient. 
I feel really sorry for the healthcare workers 
who have to explain to people and try and 
make a plan.’
The HIV Clinicians Society recently drew 
up a drug substitution guideline list, but stock-
outs leave diabetic or hypertensive patients 
instantly vulnerable. Venter said he believed 
the National Health Deparment ‘has huge 
frustrations with the provinces – everyone at 
national [level] says this is indefensible. That’s 
great, but it doesn’t help! I think there’s very 
limited accountability. Public sector salaries are 
good, so it’s just not OK that systems are failing, 
or to whine about insufficient staff. We got this 
right with less staff and relatively less pay five 
years ago. Things were working. Twenty years 
ago things were working very well. It’s got 
much worse.’ Venter said this is ‘particularly 
sad’ because the ARV programme has been 
‘such a massive success’. 
Asked about stock-outs of the much-
touted new FDCs, Venter questioned how 
effective healthcare worker education is 
regarding FDC dispensing guidelines. 
He explained that HIV-positive pregnant 
women and new patients are supposed to be 
prioritised for FDCs. ‘It seems they [clinic 
staff] would realise that having done this 
[priority dispensing], there were lots of 
drugs left over, so they transitioned chronic 
patients across – and that’s when the stock-
outs crisis started.’
Understanding supply 
and demand ‘vital’
Venter’s theory is supported by the combined 
NGO report on the stock-outs, which predicts 
that competent management of single 
ARV drug stocks will be vital as increasing 
numbers of patients experience FDC contra-
indications (e.g. renal dysfunction) or first-
line ART failure. ‘The management of single 
drug stocks may become more difficult and 
stock-outs of these options may increase over 
time as stocks get smaller.’ 
The report said that ‘just months’ after the 
national [priority-phased] roll-out of FDCs 
in April this year, shortages were already 
being reported. A major and unexpected 
cause was that manufacturers were producing 
below capacity because of ‘machinery 
updates’, and as a result some health facilities 
were getting very small quantities of FDCs, 
insufficient to meet the needs of the ‘priority 
groups’ (i.e. new ARV patients, HIV-positive 
pregnant women and ‘triple-therapy stable’ 
breastfeeding mothers). The report warned 
that as more patients became eligible for 
FDC, vigilance would be needed to ensure 
an adequate supply. 
State dysfunction costing 
patients jobs
The NGO report said that some patients are 
also beginning to lose their jobs after taking 
every Thursday off over several weeks in the 
vain hope of securing ARV drugs. Among 
the dramas surrounding the stock-outs was 
a ‘sit-in’ by 50 patients at the Village Clinic 
in Lusikisiki, Eastern Cape, who’d been told 
that the ARV efavirenz was out of stock and 
that there were insufficient FDC drugs. 
The Democratic Nursing Organisation of 
South Africa, (DENOSA) reported that 
angry patients are labelling its members as 
‘uncaring professionals that deprive patients 
of medication’, and called for the Public 
Protector to urgently probe the drug stock-
outs.
Gauteng provincial spokesman Chris 
Maxon blamed the shortage on ‘supplier 
capacity challenges’, while the province’s 
Health MEC Hope Papo visited Daveyton 
clinics to check on reported improvements. 
Papo promised that ‘in time’, adherent 
patients who were in a stable condition 
would get 3-month supplies of drugs to 
minimise travel costs. 
The compilers of the NGO report 
confirmed that the national health 
department plans to implement direct 
deliveries to facilities, bypassing depots, 
with pilot projects underway in Limpopo 
and KwaZulu-Natal. However, they warned 
that this will probably only be practical 
for large deliveries. The department is also 
considering direct deliveries to the patients’ 
homes or for collection in stores, with pilot 
projects planned next year. The collective 
report singled out the Eastern Cape health 
department for its harshest criticism, saying 
it seemed ‘unable or unwilling,’ to address 
drug supply problems in spite of knowing of 
them for several years, and having ‘immense 
support’ from civil society. It suggested 
that national health minister Dr Aaron 
Motsoaledi use his constitutional powers 
to intervene on an emergency basis to bring 
health services back in line with national 
standards.
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The Mthata depot was described 
by Pillay in a November 2012 
report, as ‘unmanageable and 
unnecessary’ because it was ‘rife 
with corruption, widespread 
theft and labour problems’. He 
proposed bringing in the army 
to stem ongoing losses which he 
estimated at R250 million a year.
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